... Cardio-oncology Cardiotoxicity SGLT2 inhibitors (SGLT2i) Cancer therapy-related cardiac dysfunction (CTRCD) Heart failure hospitalization Preventive cardiology ACCEPTED MANUSCRIPT 1 Effects of SGLT2 Inhibitors in Patients with Cancer and Diabetes Mellitus: A 2 Systematic Review and Meta-analysis 3 4...

.../by/4.0/ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Radiotherapy Cardio-oncology Biomarkers Coronary inflammation Cardiovascular risk Computed tomography imaging British Heart Foundation 10.13039/501100000274 FS...

... for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. Carcinoid syndrome Cardio-oncology Echocardiography Tricuspid...

... the importance of interdisciplinary work-up of a cardio-oncology pathway even in presumably low-risk patients and particularly in the context of rare cases of cardiotoxicity in novel cancer treatments. We report a case of a 24-year-old man without pre-existing cardiovascular disease who developed...

... Abstract Graphical Abstract Heart failure Sodium–glucose cotransporter 2 inhibitor Anthracycline Cancer Cardiotoxicity Cardio-oncology NIHR 10.13039/501100000272 Academic Clinical Fellows in Cardiology Doctoral Research Fellowship Cancer is currently the leading cause of pre-mature...

... of this population to improve outcomes. Graphical Abstract Graphical Abstract Heart failure Cardiogenic shock Cardio-oncology Patients with cancer are at higher risk of heart failure (HF) compared with patients without cancer, which may be due to shared underlying risk factors and pathophysiology...

... or transformed in any way, and that the work is properly cited. For commercial re-use, please contact [email protected] Abstract Aims The Council of Cardio-Oncology of the European Society of Cardiology developed an on-line anonymous survey to provide an overall picture of the current practice...

..., and the growing involvement of specialized cardio-oncology clinics in cancer patient care, healthcare providers are now more vigilant in diagnosing this condition. These developments have led to an increased detection of NBTE in the appropriate clinical settings. There has been a significantly increased interest...

... 05 03 2024 12 05 2024 01 11 2024 04 12 2024 Case report Cardio-oncology Immunotherapy-related adverse events Myocarditis Coronary vasospasm Cardiac MRI © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. 2024...

... cardiovascular toxicities. Therefore, understanding the common risk factors and underlying pathophysiological mechanisms contributing to cardiovascular toxicity is essential to ensure best breast cancer outcomes. While cardio-oncology has emerged as a sub-speciality to address these challenges, it is essential...

.../ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Aims The need for cardio-oncology competencies is constantly growing, and with the establishment of cardio-oncology services, cardiovascular imaging, particularly...

... reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Cardio-oncology Takotsubo syndrome Cancer therapy Immune checkpoint inhibitors Endomyocardial biopsy Case report Learning points To understand the importance of establishing an accurate...

... unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background Patients with cancer are at an increased risk of thrombus formation, often identified on routine echocardiogram in the right atrium. The 2022 ESC Guidelines on Cardio-oncology...

... inhibitors Coronary artery disease Cardiovascular disease Atherosclerotic cardiovascular disease Cardiovascular risk factors Cardio-oncology National Health and Medical Research Council 10.13039/501100000925 National Heart Foundation of Australia 10.13039/501100001030 Cancer survivorship has...

...Bénédicte Manderlier; Berlinde von Kemp; Katrien Beeckman; Bernard Cosyns; Karen Van den Bussche; cardio-oncology expert panel; Robyn A Clark; Jonathon Foote; Jeroen Hendriks; Sofie Gevaert; Marie Moonen; Petra Nijst; Julie De Bolle; Maria Luiza Luchian; Marc Van der Hoogerstraete; Mathilde De...

... permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact [email protected]. Abstract Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer rehabilitation but also a pillar...

... in these patients. DOAC direct oral anticoagulant DVT deep vein thrombosis PE pulmonary embolism VTE venous thromboembolism Anticoagulant regimen Cancer Cardio-oncology Deep vein thrombosis Edoxaban Abstract Background The ONCO DVT study revealed the superiority of 12-month relative...